Trails Edge Capital Partners, LP

CIK

2077247

Location

ATLANTA, GA

Portfolio Value

Small $436,527,513

Diversification

Diversified

Filing Date

Global Rank

#2,798 / 8,603 ▲ 326 · as of Mar 2026

Top Industry

Biotechnology 100.0%

3Y Alpha vs SPY

+105.8%

Period ended 3 months ago

Filed May 15, 2026 · 55d

2 quarters · since Dec 2025

Clone Performance

Feb 2026–Jul 2026 · vs SPY

Hypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.

Cloned portfolio

+40.7%

SPY

+10.0%

Annualised alpha

+109.4%

Max drawdown

−12.0%

Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.

Portfolio Concentration

26 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025

Top Position

8.8%

−1.4 pts

Top 5

39.4%

−4.6 pts

Top 10

65.5%

−4.2 pts

HHI

539

Diversified−77

Portfolio Trend

2 quarters · across all stocks

Sector Breakdown

As of Mar 31, 2026

Sector	% Portfolio	Value	Positions
Healthcare	100.0%	$436,527,513	26

Last Quarter's Activity

Export CSV

Mar 31, 2026 vs Dec 31, 2025

Added To

Positions the filer increased

5 positions

Ticker	Company	Δ Shares	Shares	Value
IKT	Inhibikase Therapeutics, Inc.	+1,879,221	8,057,345	$13,536,339
MIRM	Mirum Pharmaceuticals, Inc.	+301,450	333,312	$30,791,362
IMVT	Immunovant, Inc.	+173,889	414,054	$10,285,101
RCUS	Arcus Biosciences, Inc.	+131,622	1,047,935	$22,635,396
XENE	Xenon Pharmaceuticals Inc.	+42,908	640,000	$37,216,000
No positions match the current search.

Trimmed

Positions the filer reduced

5 positions

Ticker	Company	Δ Shares	Shares	Value
VTVT	vTv Therapeutics Inc.	−91,422	139,578	$5,535,663
LBRX	Lb Pharmaceuticals Inc	−76,246	1,319,362	$32,535,466
PCVX	Vaxcyte, Inc.	−75,000	662,470	$38,496,131
CAMP	Camp4 Therapeutics Corp	−44,423	1,939,563	$8,553,472
NGNE	Neurogene Inc.	−2,213	782,787	$15,780,985
No positions match the current search.

New Positions

Positions the filer opened this quarter

12 positions

Ticker	Company	Shares	Value
DFTX	Definium Therapeutics, Inc.	1,738,110	$32,850,279
RVMD	Revolution Medicines, Inc.	245,000	$23,826,250
CYTK	Cytokinetics Inc	300,000	$19,773,000
SNDX	Syndax Pharmaceuticals Inc	701,821	$16,394,538
FDMT	4D Molecular Therapeutics, Inc.	1,302,917	$12,130,157
DSGN	Design Therapeutics, Inc.	852,013	$9,065,418
NERV	Minerva Neurosciences, Inc.	1,419,000	$8,549,475
PMN	ProMIS Neurosciences Inc.	557,103	$7,075,208
SLGL	Sol-Gel Technologies Ltd.	85,496	$6,772,993
IPSC	Century Therapeutics, Inc.	2,449,993	$5,536,984
FTH	Faeth Therapeutics, Inc.	125,000	$3,940,000
IRD	Opus Genetics, Inc.	500,000	$2,275,000
No positions match the current search.

Sold Out

Positions the filer fully exited

8 positions

Ticker	Company	Shares	Value
ACAD	Acadia Pharmaceuticals Inc	1,419,406	$37,912,334
TYRA	Tyra Biosciences, Inc.	700,000	$18,403,000
FOLD	AMICUS THERAPEUTICS, INC.	1,043,313	$14,856,777
APGE	Apogee Therapeutics, Inc.	192,000	$14,492,160
TERN	Terns Pharmaceuticals, Inc.	300,000	$12,120,000
MBX	MBX Biosciences, Inc.	315,158	$9,940,083
CMPX	Compass Therapeutics, Inc.	1,415,273	$7,600,016
ELVN	Enliven Therapeutics, Inc.	199,306	$3,069,312
No positions match the current search.

Portfolio Positions

Compact Export CSV View 13F filing

26 positions · $436,527,513 total · as of Mar 31, 2026

All sectors Healthcare

Ticker	Company	Type	Shares	Δ Shares	Value (USD)	% Δ Value	% of Portfolio
PCVX	Vaxcyte, Inc. Healthcare	Reduced	662,470	-75,000	$38,496,131	+13.1%	8.82%
XENE	Xenon Pharmaceuticals Inc. Healthcare	Added	640,000	+42,908	$37,216,000	+39.1%	8.53%
DFTX	Definium Therapeutics, Inc. Healthcare	NEW	1,738,110	NEW	$32,850,279	NEW	7.53%
LBRX	Lb Pharmaceuticals Inc Healthcare	Reduced	1,319,362	-76,246	$32,535,466	+4.7%	7.45%
MIRM	Mirum Pharmaceuticals, Inc. Healthcare	Added	333,312	+301,450	$30,791,362	+1123.4%	7.05%
NRIX	Nurix Therapeutics, Inc. Healthcare	Held	1,743,220	0	$27,019,910	−18.3%	6.19%
RVMD	Revolution Medicines, Inc. Healthcare	NEW	245,000	NEW	$23,826,250	NEW	5.46%
RCUS	Arcus Biosciences, Inc. Healthcare	Added	1,047,935	+131,622	$22,635,396	+3.7%	5.19%
IMCR	Immunocore Holdings plc Healthcare	Held	682,597	0	$20,580,299	−13.1%	4.71%
CYTK	Cytokinetics Inc Healthcare	NEW	300,000	NEW	$19,773,000	NEW	4.53%
SNDX	Syndax Pharmaceuticals Inc Healthcare	NEW	701,821	NEW	$16,394,538	NEW	3.76%
NGNE	Neurogene Inc. Healthcare	Reduced	782,787	-2,213	$15,780,985	−2.4%	3.62%
IVA	Inventiva S.A. Healthcare	Held	2,657,997	0	$14,751,883	+19.4%	3.38%
IKT	Inhibikase Therapeutics, Inc. Healthcare	Added	8,057,345	+1,879,221	$13,536,339	+6.9%	3.10%
FDMT	4D Molecular Therapeutics, Inc. Healthcare	NEW	1,302,917	NEW	$12,130,157	NEW	2.78%
XFOR	X4 Pharmaceuticals, Inc Healthcare	Reduced	2,571,478	-5,227,222	$10,620,204	−66.0%	2.43%
IMVT	Immunovant, Inc. Healthcare	Added	414,054	+173,889	$10,285,101	+68.5%	2.36%
DSGN	Design Therapeutics, Inc. Healthcare	NEW	852,013	NEW	$9,065,418	NEW	2.08%
CAMP	Camp4 Therapeutics Corp Healthcare	Reduced	1,939,563	-44,423	$8,553,472	−29.7%	1.96%
NERV	Minerva Neurosciences, Inc. Healthcare	NEW	1,419,000	NEW	$8,549,475	NEW	1.96%
PMN	ProMIS Neurosciences Inc. Healthcare	NEW	557,103	NEW	$7,075,208	NEW	1.62%
SLGL	Sol-Gel Technologies Ltd. Healthcare	NEW	85,496	NEW	$6,772,993	NEW	1.55%
IPSC	Century Therapeutics, Inc. Healthcare	NEW	2,449,993	NEW	$5,536,984	NEW	1.27%
VTVT	vTv Therapeutics Inc. Healthcare	Reduced	139,578	-91,422	$5,535,663	−40.1%	1.27%
FTH	Faeth Therapeutics, Inc. Healthcare	NEW	125,000	NEW	$3,940,000	NEW	0.90%
IRD	Opus Genetics, Inc. Healthcare	NEW	500,000	NEW	$2,275,000	NEW	0.52%